Jim Cramer - Mad MoneyInsmed INSMDON'T BUYJul 09, 2025

Too speculative. They lose money.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$96.47

Stock price when the opinion was issued

$126.33

As of Aug 13, 2026. Market Open.

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

WATCH

Up 152% last year. They got FDA approval for one of their top drugs last year to treat a lung condition. It pulled back 18% last month due to a disappointing trial result in a drug. Worth watching this.

Most Recent Experts

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Shannon Saccocia, CIO, Boston Private

Boston Private

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Jim Cramer - Mad MoneyInsmed INSMDON'T BUYJul 09, 2025

You might be interested:

Insmed (INSM)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals